Dendrofalconerol A sensitizes anoikis and inhibits migration in lung cancer cells

J Nat Med. 2015 Apr;69(2):178-90. doi: 10.1007/s11418-014-0876-2. Epub 2014 Nov 13.

Abstract

Resistance to anoikis, enhanced cell motility, and growth in anchorage-independent conditions are hallmarks of highly metastatic cancer cells. The present study demonstrates the anoikis-sensitizing and anti-migration activities of dendrofalconerol A (DF-A), a pure bis(bibenzyl) isolated from the stem of Dendrobium falconeri (Orchidaceae), and its underlying mechanisms in human lung cancer H460 cells. DF-A at non-toxic concentrations significantly increased the anoikis response of the cancer cells, but caused no toxic effect on normal keratinocytes. In addition, DF-A significantly inhibited the growth of lung cancer cells in anchorage-independent conditions. Western blot analysis revealed that the anoikis-sensitizing effect of such a compound involves its ability to suppress survival signals as well as anti-apoptotic proteins, namely, activated protein kinase B (Akt) and Bcl-2. Furthermore, DF-A decreased caveolin-1 (Cav-1), a protein responsible for aggressiveness, while having no effect on Bax, Mcl-1, and activated Erk (p42/44) proteins. In the case of cell motility, DF-A exhibited strong anti-migration activity with the mechanism involving suppression of pFAK and Rho-GTP, but had no effect on Rac-GTP in lung cancer cells. Taken together, DF-A possesses anoikis-sensitizing activity along with anti-migration effects, and may be developed as a novel active compound for cancer treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anoikis / drug effects*
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Bibenzyls / isolation & purification
  • Bibenzyls / pharmacology
  • Bibenzyls / therapeutic use*
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Dendrobium / chemistry*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Phytotherapy*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Signal Transduction / drug effects
  • Xanthenes / isolation & purification
  • Xanthenes / pharmacology
  • Xanthenes / therapeutic use*

Substances

  • 4,6-dimethoxy-9-(4-methoxybenzyl)-8-(2-(4-methoxyphenyl)ethyl)-9H-xanthene-2,3,5-triol
  • Antineoplastic Agents, Phytogenic
  • Bibenzyls
  • Plant Extracts
  • Proto-Oncogene Proteins c-bcl-2
  • Xanthenes